Related Experiment Video
Updated: Jul 14, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis
Elvia García-López1, Juan J Carrero, Mohamed E Suliman
1Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Insights
Patients undergoing peritoneal dialysis (PD) face significant cardiovascular risks due to uremia and PD-related factors. This review explores inflammation, insulin resistance, and genetics in PD patients to improve cardiovascular outcomes.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Patients on peritoneal dialysis (PD) exhibit a high prevalence of cardiovascular disease.
- Cardiovascular risk factors are amplified by the uremic environment, including inflammation, oxidative stress, and mineral imbalances.
- Diabetes mellitus and hypertension are common comorbidities that accelerate kidney disease and cardiovascular progression.
Purpose of the Study:
- To review recent advancements in cardiovascular research concerning the PD population.
- To discuss emerging therapy trends for managing cardiovascular risk in PD patients.
- To highlight the impact of specific factors like inflammation, insulin resistance, and genetics on cardiovascular health in PD.
Main Methods:
- Literature review of recent findings in cardiovascular research on PD patients.
- Analysis of factors associated with PD therapy that influence cardiovascular risk.
- Emphasis on the roles of inflammation, insulin resistance, homocysteinemia, dyslipidemia, vascular calcification, and genetics/epigenetics.
Main Results:
- PD patients face multifaceted cardiovascular risks from both uremic milieu and PD treatment itself.
- Factors such as altered lipid profiles, hyperinsulinemia, and advanced glycation end-products can increase cardiovascular risk.
- Conversely, PD may offer benefits through improved blood pressure control and anemia management.
Conclusions:
- Understanding the complex interplay of factors influencing cardiovascular risk in PD is crucial.
- Targeting inflammation, insulin resistance, dyslipidemia, and genetic predispositions may mitigate cardiovascular complications.
- Further research and tailored therapeutic strategies are needed to optimize cardiovascular health in PD patients.
Abstract:
Patients on peritoneal dialysis (PD) are at high cardiovascular risk. Although some risk factors are unmodifiable (for example, age, sex, genetics), others are exacerbated in the unfriendly uremic milieu (inflammation, oxidative stress, mineral disturbances) or contribute per se to kidney disease and cardiovascular progression (diabetes mellitus, hypertension). Moreover, several factors associated with PD therapy may both increase (by altered lipid profile, hyperinsulinemia, and formation of advanced glycation end-products) and decrease (by better blood pressure control and anemia management) cardiovascular risk. The present review discusses recent findings and therapy trends in cardiovascular research on the PD population, with emphasis on the roles of inflammation, insulin resistance, homocysteinemia, dyslipidemia, vascular calcification, and genetics/epigenetics.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Peritoneal Dialysis I: Introduction and Procedure
